Zusammenfassung
Mit der Änderung der chirurgischen Taktik bei Patienten mit primärem Hyperparathyreoidismus
zugunsten einer minimalinvasiven Vorgehensweise gewinnt die präoperative Darstellung
von pathologisch veränderten Nebenschilddrüsen an Bedeutung. Neben anatomischen Lokalisationsmethoden
bietet die Nebenschilddrüsenszintigrafie die Möglichkeit, morphologisch schwer erkennbare
Strukturen zu detektieren, da die Lokalisation hier primär auf funktionellen Eigenschaften
des Zielgewebes beruht. Ziel der Arbeit ist es, einen aktuellen Überblick über die
Möglichkeiten der Nebenschilddrüsenlokalisationsdiagnostik zu geben. Insbesondere
werden die diagnostischen Möglichkeiten bei kombinierter Verwendung von synergistischen
Verfahren im Sinne einer anatomisch-funktionellen Bildgebung dargestellt. In Conclusio
empfehlen wir vor einer minmalinvasiven Intervention zur Sanierung eines Hyperparathyreoidismus
die kombinierte sonografisch-szintigrafische Nebenschilddrüsenlokalisationsdiagnostik,
bestehend aus sequenzieller 99 m Tc-Sestamibi-Szintigrafie inklusive SPECT plus Schilddrüsenszintigrafie und hochauflösender
zervikaler Sonografie.
Abstract
In patients with primary hyperparathyroidism (pHPT) considered for surgery there has
been increasing stress laid upon minimally invasive procedures in recent years. Precise
localization prior to surgery is crucial in this context. Besides high-resolution
ultrasonography, functional imaging using 99 m Tc-Sestamibi is gaining importance as scintigraphic localization primarily relays
on functional features than on morphologic appearance. The purpose of this review
is to summarize the accuracy of different diagnostic imaging methods in pHPT with
respect to synergistic anatomic and functional imaging. In conclusion we recommend
prior to minimally invasive treatment of hyperparathyroidism combined localization
studies, consisting of sequential 99 m Tc-Sestamibi scintigraphy, additional SPECT plus thyroid gland scintigraphy, plus
high-resolution cervical ultrasonography.
Schlüsselwörter
Primärer Hyperparathyreoidismus - Lokalisationsdiagnostik -
99 m Tc-Sestamibi-Szintigrafie - Ultraschall - minimalinvasive Chirurgie
Key words
hyperparathyroidism -
99 m Tc-Sestamibi scintigraphy - ultrasound - minimal-invasive surgery
Literatur
1
Silverberg S J, Shane E, Jacobs T P. et al .
A 10-year prospective study of primary hyperparathyroidism with or without parathyroid
surgery.
N Engl J Med.
1999;
341
1301-1302
2
Bilezikian J P, Potts Jr J T, Fuleihan G H. et al .
Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective
for the 21st century.
J Clin Endocrinol Metab.
2002;
87
5353-5361
3
Frilling A, Görges R, Clauer U. et al .
Minimal-invasive Parathyreoidektomie in Lokalanaesthesie in Verbindung mit Ultrasonographie,
Sestamibi-Szintigraphie und intraoperativer Parathormonmessung.
Chirurg.
2000;
71
1474-1479
4
Garner S C, Leight Jr G S.
Initial experience with intraoperative PTH determinations in the surgical management
of 130 consecutive cases of primary hyperparathyroidism.
Surgery.
1999;
126
1132-1138
5
Carty S E, Worsey J, Virji M A. et al .
Concise pararthyroidectomy: the impact of preoperative SPECT 99 mTc sestamibi scanning
and intraoperative quick parathormone assay.
Surgery.
1997;
122
1107-1116
6
Sheu S Y, Otterbach F, Frilling A. et al .
Hyperplasien und Tumoren der Nebenschilddrüsen.
Pathologe.
2003;
24
373-381
7 Raue F, Schilling T. Hyper- und Hypoparathyreoidismus. Ganten G, Ruckpaul K, Janssen
OE, Heufelder AE Molekularmedizinische Grundlagen von Endokrinopathien Berlin/Heidelberg;
Springer Verlag 2001: 111-136
8 Janssen O E, Scriba P C. Primärer Hyperparathyreoidismus. Classen M, Diehl V, Koch
KM, Kochsiek K, Pongratz D, Scriba PC Differentialdiagnose Innere Medizin München/Wien/Baltimore;
Urban und Schwarzenberg 1998: 151-153
9 Ziegler R, Pickardt C R, Willig R P. Rationelle Diagnostik in der Endokrinologie
einschließlich Diabetologie und Stoffwechsel. Stuttgart/New York; Georg Thieme Verlag
1993
10 Ziegler R, Landgraf R, Müller O A. et al .Rationelle Therapie in der Endokrinologie
einschließlich Diabetologie und Stoffwechsel. Stuttgart/New York; Georg Thieme Verlag
1997
11 Herrmann F, Müller P, Lohmann T. Endokrinologie für die Praxis. Stuttgart/New York;
Georg Thieme Verlag 2002
12
Koslin D B, Adams J, Andersen P. et al .
Preoperative evaluation of patients with primary hyperparathyroidism: role of high-resolution
ultrasound.
Laryngoscope.
1997;
107 (9)
1249-1253
13
Ulanovski D, Feinmesser R, Cohen M. et al .
Preoperative evaluation of patients with parathyroid adenoma: role of high-resolution
ultrasonography.
Head Neck.
2002;
24 (1)
1-5
14
Catargi B, Raymond J M, Lafarge-Gense V. et al .
Localization of parathyroid tumors using endoscopic ultrasonography in primary hyperparathyroidism.
J Endocrinol Invest.
1999;
22 (9)
688-692
15
Saleh A, Santen R, Malms J. et al .
B-Mode-Sonographie und moderne dopplerdiagnostische Methoden bei Krankheiten der Schilddrüse
und der Nebenschilddrüsen.
Radiologe.
1998;
38 (5)
344-354
16
Freudenberg L S, Jentzen W, Antoch G. et al .
Accidental detection of a parathyroid adenoma by fluorine-18 fluordeoxyglucose positron
emission tomography/computed tomography (FDG-PET/CT).
Turk J Nucl Med.
2005;
13
49-51
17
Profanter C, Wetscher G J, Gabriel M. et al .
CT-MIBI image fusion: a new preoperative localization technique for primary, recurrent,
and persistent hyperparathyroidism.
Surgery.
2004;
135
157-162
18
Taillefer R, Boucher Y, Potvin C. et al .
Detection and localization of parathyroid adenomas in patients with hyperparathyroidism
using a single radionuclide imaging procedure with technetium-99 m-sestamibi (double-phase
study).
J Nucl Med.
1992;
33 (10)
1801-1807
19
Berczi C, Mezosi E, Galuska L. et al .
Technetium-99 m-sestamibi/pertechnetate subtraction scintigraphy vs ultrasonography
for preoperative localization in primary hyperparathyroidism.
Eur Radiol.
2002;
12 (3)
605-609
20
Berna L, Piera J, Rodriguez-Espinosa J. et al .
Isotopic study with double phase 99 mTc-sestamibi in the localization of parathyroid
gland lesions.
Med Clin (Barc).
1999;
112 (6)
201-205
21
Castellani M, Reschini E, Longari V. et al .
Role of Tc-99 m sestamibi scintigraphy in the diagnosis and surgical decision-making
process in primary hyperparathyroid disease.
Clin Nucl Med.
2001;
26 (2)
139-144
22
De Feo M L, Colagrande S, Biagini C. et al .
Parathyroid glands: combination of (99 m)Tc MIBI scintigraphy and US for demonstration
of parathyroid glands and nodules.
Radiology.
2000;
214 (2)
393-402
23
Feingold D L, Alexander H R, Chen C C. et al .
Ultrasound and sestamibi scan as the only preoperative imaging tests in reoperation
for parathyroid adenomas.
Surgery.
2000;
128 (6)
1103-1109
24
Geatti O, Shapiro B, Orsolon P G. et al .
Localization of parathyroid enlargement: experience with technetium-99 m methoxyisobutylisonitrile
and thallium-201 scintigraphy, ultrasonography and computed tomography.
Eur J Nucl Med.
1994;
21 (1)
17-22
25
Gotway M B, Reddy G P, Webb W R. et al .
Comparison between MR imaging and 99 mTc MIBI scintigraphy in the evaluation of recurrent
of persistent hyperparathyroidism.
Radiology.
2001;
218 (3)
783-790
26
Haber R S, Kim C K, Inabnet W B.
Ultrasonography for preoperative localization of enlarged parathyroid glands in primary
hyperparathyroidism: comparison with (99 m)technetium sestamibi scintigraphy.
Clin Endocrinol (Oxf).
2002;
57 (2)
241-249
27
Hindie E, Melliere D, Jeanguillaume C. et al .
Parathyroid imaging using simultaneous double-window recording of technetium-99 m-sestamibi
and iodine-123.
J Nucl Med.
1998;
39 (6)
1100-1105
28
Jones J M, Russell C F, Ferguson W R. et al .
Pre-operative sestamibi-technetium subtraction scintigraphy in primary hyperparathyroidism:
experience with 156 consecutive patients.
Clin Radiol.
2001;
56 (7)
556-559
29
Lumachi F, Zucchetta P, Marzola M C. et al .
Advantages of combined technetium-99 m-sestamibi scintigraphy and high-resolution
ultrasonography in parathyroid localization: comparative study in 91 patients with
primary hyperparathyroidism.
Eur J Endocrinol.
2000;
143 (6)
755-760
30
Moka D, Eschner W, Voth E. et al .
Iterative reconstruction: an improvement of technetium-99 m MIBI SPET for the detection
of parathyroid adenomas?.
Eur J Nucl Med.
2000;
27 (5)
485-489
31
Moka D, Voth E, Dietlein M. et al .
Technetium 99 m-MIBI-SPECT: A highly sensitive diagnostic tool for localization of
parathyroid adenomas.
Surgery.
2000;
128 (1)
29-35
32
Perez-Monte J E, Brown M L, Shah A N. et al .
Parathyroid adenomas: accurate detection and localization with Tc-99 m sestamibi SPECT.
Radiology.
1996;
201 (1)
85-91
33
Purcell G P, Dirbas F M, Jeffrey R B. et al .
Parathyroid localization with high-resolution ultrasound and technetium Tc 99 m sestamibi.
Arch Surg.
1999;
134 (8)
824-828; discussion 828 - 830
34
Sfakianakis G N, Irvin 3rd G L, Foss J. et al .
Efficient parathyroidectomy guided by SPECT-MIBI and hormonal measurements.
J Nucl Med.
1996;
37 (5)
798-804
35
Takebayashi S, Hidai H, Chiba T. et al .
Hyperfunctional parathyroid glands with 99 mTc-MIBI scan: semiquantitative analysis
correlated with histologic findings.
J Nucl Med.
1999;
40 (11)
1792-1797
36
Takei H, Iino Y, Endo K. et al .
The efficacy of technetium-99 m-MIBI scan and intraoperative methylene blue staining
for the localization of abnormal parathyroid glands.
Surg Today.
1999;
29 (4)
307-312
37
Weiss M, Beneke F, Schmid R. et al .
Can supplemental imaging with SPECT technique improve the diagnostic value of preoperative
Tc-99 m-MIBI scintigraphy in primary hyperparathyroidism?.
Med Klin.
2002;
97 (7)
389-395
38
Carpentier A, Jeannotte S, Verreault J. et al .
Preoperative localization of parathyroid lesions in hyperparathyroidism: relationship
between technetium-99 m-MIBI uptake and oxyphil cell content.
J Nucl Med.
1998;
39 (8)
1441-1444
39
Apostolopoulos D J, Houstoulaki E, Giannakenas C. et al .
Technetium-99 m-tetrofosmin for parathyroid scintigraphy: comparison to thallium-technetium
scanning.
J Nucl Med.
1998;
39 (8)
1433-1441
40
Fjeld J G, Erichsen K, Pfeffer P F. et al .
Technetium-99 m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi.
J Nucl Med.
1997;
38 (6)
831-834
41
Gallowitsch H J, Mikosch P, Kresnik E. et al .
Technetium 99 m tetrofosmin parathyroid imaging. Results with double-phase study and
SPECT in primary and secondary hyperparathyroidism.
Invest Radiol.
1997;
32 (8)
459-465
42
Gallowitsch H J, Mikosch P, Kresnik E. et al .
Comparison between 99 mTc-tetrofosmin/pertechnetate subtraction scintigraphy and 99
mTc-tetrofosmin SPECT for preoperative localization of parathyroid adenoma in an endemic
goiter area.
Invest Radiol.
2000;
35 (8)
453-459
43
Giordano A, Marozzi P, Meduri G. et al .
Quantitative comparison of technetium-99 m tetrofosmin and thallium-201 images of
the thyroid and abnormal parathyroid glands.
Eur J Nucl Med.
1999;
26 (8)
907-911
44
Ishibashi M, Nishida H, Hiromatsu Y. et al .
Comparison of technetium-99 m-MIBI, technetium-99 m-tetrofosmin, ultrasound and MRI
for localization of abnormal parathyroid glands.
J Nucl Med.
1998;
39 (2)
320-324
45
McGreal G, Winter D C, Sookhai S. et al .
Minimally invasive, radioguided surgery for primary hyperparathyroidism.
Ann Surg Oncol.
2001;
8 (10)
856-860
46 Bockisch A, Piepenburg R, Diaz M. Szintigraphische Lokalisationsdiagnostik von
hyperaktivem Nebenschilddrüsengewebe. Beyer J, Junginger T, Lehnert H, Walgenbach
S Diagnostische und chirurgische Aspekte bei endokrinen Erkrankungen Sympomed 1993
47
Diaz M, Bockisch A, Hahn K. et al .
Szintigraphische Darstellung ektoper Nebenschilddrüsenadenome mit 99 mTcMIBI 2 Fallbeispiele.
Nucl Med.
1994;
33
42-45
48
Neumann D R, Esselstyn C B, Maclntyre W J. et al .
Comparison of FDG-PET and sestamibi-SPECT in primary hyperparathyroidism.
J Nucl Med.
1996;
37 (11)
1809-1815
49
Sundin A, Johansson C, Hellman P. et al .
PET and parathyroid L-[carbon-11] methionine accumulation in hyperparathyroidism.
J Nucl Med.
1996;
37 (11)
1766-1770
50
Adalet I, Hawkins T, Clark F. et al .
Thallium-technetium-subtraction scintigraphy in secondary hyperparathyroidism.
Eur J Nucl Med.
1994;
21 (6)
509-513
51
Huang S H, Lai I R, Liaw K Y. et al .
Preoperative localization procedures for initial surgery in primary hyperparathyroidism.
J Formos Med Assoc.
1998;
97 (10)
679-683
52
Krausz Y, Lebensart P D, Klein M. et al .
Preoperative localization of parathyroid adenoma in patients with concomitant thyroid
nodular disease.
World J Surg.
2000;
24 (12)
1573-1578
53
Kruse H P, Kuhlencordt F, Ringe J D. et al .
Preoperative localization diagnosis of parathyroid adenomas in 72 cases of primary
hyperparathyroidism by selective catheterization of neck veins and parathyroid hormone
determination.
Schweiz Med Wochenschr.
1983;
113 (17)
636-640
54
Lumachi F, Ermani M, Basso S. et al .
Localization of parathyroid tumours in the minimally invasive era: which technique
should be chosen? Population-based analysis of 253 patients undergoing parathyroidectomy
and factors affecting parathyroid gland detection.
Endocr Relat Cancer.
2001;
8 (1)
63-69
55
Rotstein L, Irish J, Gullane P. et al .
Reoperative parathyroidectomy in the era of localization technology.
Head Neck.
1998;
20 (6)
535-539
56
Scheiner J D, Dupuy D E, Monchik J M. et al .
Pre-operative localization of parathyroid adenomas: a comparison of power and colour
Doppler ultrasonography with nuclear medicine scintigraphy.
Clin Radiol.
2001;
56 (12)
984-988
57
Van Dalen A, Smit C P, Vroonhoven T J. et al .
Minimally invasive surgery for solitary parathyroid adenomas in patients with primary
hyperparathyroidism: role of US with supplemental CT.
Radiology.
2001;
220 (3)
631-639
58
Freudenberg L S, Frilling van A, Sheu S. et al .
Optimizing Preoperative Imaging in Primary Hyperparathyroidism.
Langenbecks Arch Surg.
2006;
391 (6)
551-556
Dr. med. Lutz S. Freudenberg, M.A., M.B.A.
Klinik für Nuklearmedizin, Universität Essen
Hufelandstraße 55
45122 Essen
Telefon: ++ 49/2 01/7 23 20 32
Fax: ++ 49/2 01/7 23 59 64
eMail: lutz.freudenberg@uni-essen.de